STOCK TITAN

Mangoceuticals (MGRX) Stock News, Dec 2023-Apr 2024

MGRX Nasdaq

Mangoceuticals, Inc. develops, markets and sells health and wellness products through a secure telemedicine platform under the MangoRx and PeachesRx brands. Company news commonly covers telehealth programs for erectile dysfunction, hair growth, hormone replacement therapy and weight management, including prescription access and fulfillment through pharmacy partners when medically appropriate.

Recurring updates also include product and intellectual-property developments such as MGX-0024, an antiviral animal feed and drinking water additive technology, as well as capital actions, platform operations and legal matters involving technology vendors. The company’s releases often connect its wellness brands, digital consultation model and eCommerce infrastructure to new treatment categories and operating initiatives.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.37%
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.03%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.39%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.51%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.01%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.87%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-40.97%
Tags

FAQ

What is the current stock price of Mangoceuticals (MGRX)?

Mangoceuticals (MGRX) last closed at $0.2899.

What is the market cap of Mangoceuticals (MGRX)?

The market cap of Mangoceuticals (MGRX) is approximately $6.4M.